| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 262.55B | 251.37B | 226.71B | 228.06B | 207.97B | 209.12B |
| Gross Profit | 121.69B | 116.54B | 104.78B | 106.80B | 101.09B | 87.75B |
| EBITDA | 76.13B | 74.55B | 66.11B | 67.84B | 64.45B | 55.97B |
| Net Income | 45.34B | 43.04B | 38.03B | 41.09B | 38.78B | 33.47B |
Balance Sheet | ||||||
| Total Assets | 334.50B | 330.76B | 323.46B | 298.71B | 279.69B | 265.51B |
| Cash, Cash Equivalents and Short-Term Investments | 33.55B | 27.45B | 22.74B | 29.65B | 34.66B | 32.38B |
| Total Debt | 49.82B | 40.47B | 40.98B | 27.29B | 22.71B | 22.67B |
| Total Liabilities | 98.95B | 94.58B | 92.56B | 77.19B | 71.68B | 64.95B |
| Stockholders Equity | 232.20B | 233.29B | 227.47B | 218.42B | 205.91B | 198.83B |
Cash Flow | ||||||
| Free Cash Flow | 42.68B | 43.01B | 12.70B | 15.05B | 29.10B | 30.40B |
| Operating Cash Flow | 60.17B | 59.18B | 33.70B | 35.23B | 41.95B | 39.94B |
| Investing Cash Flow | -18.16B | -17.61B | -18.74B | -19.64B | -12.39B | -12.85B |
| Financing Cash Flow | -41.65B | -35.65B | -22.10B | -25.03B | -27.87B | -25.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥696.60B | 15.42 | 20.91% | 3.41% | 13.93% | 23.19% | |
71 Outperform | $697.83B | 17.27 | 4.79% | 4.55% | -1.21% | -27.20% | |
70 Outperform | $1.06T | 29.00 | 5.90% | 1.14% | 1.60% | -6.74% | |
62 Neutral | ¥535.51B | 35.16 | 2.06% | 3.26% | 0.55% | -69.21% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | $703.12B | 8.29 | 8.79% | 2.64% | -1.64% | ― | |
54 Neutral | $1.10T | 10.09 | 1.09% | 3.97% | -11.50% | 25.86% |
Nissan Chemical Corporation announced the cancellation of 1,000,000 of its common shares, representing 0.73% of its issued shares, as decided in a Board of Directors meeting. This move is part of the company’s capital management strategy, potentially impacting shareholder value and market perception by reducing the number of outstanding shares.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6140.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.
Nissan Chemical Corporation has announced the repurchase of 308,700 of its own shares on the Tokyo Stock Exchange, amounting to a total purchase cost of 1,625,576,600 yen. This move is part of a broader strategy authorized by the Board of Directors to repurchase up to 2,500,000 shares by March 2026, which aims to enhance shareholder value and optimize the company’s capital structure.
The most recent analyst rating on (JP:4021) stock is a Hold with a Yen5300.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.
Nissan Chemical Corporation has repurchased 440,000 of its own common shares on the Tokyo Stock Exchange, amounting to a total cost of 2,022,443,700 yen, as part of its ongoing share buyback program. This move is part of a broader strategy approved by the Board of Directors to repurchase up to 2,500,000 shares by March 31, 2026, reflecting the company’s efforts to enhance shareholder value.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen5600.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.